Transcatheter Tricuspid Valve-In-Ring and Aortic Valve-In-Valve Implantation

Background  Transcatheter heart valve (THV) therapies have shown to be an alternative to surgical valve replacement, especially in high-risk patients requiring redo surgery. However, reports of transcatheter-based interventions in tricuspid valve position are scarce. Case Description  Here, we repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Reichart, Daniel, Schofer, Niklas, Deuschl, Florian, Schaefer, Andreas, Blankenberg, Stefan, Reichenspurner, Hermann, Schaefer, Ulrich, Conradi, Lenard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602643/
https://www.ncbi.nlm.nih.gov/pubmed/28929044
http://dx.doi.org/10.1055/s-0037-1606345
Descripción
Sumario:Background  Transcatheter heart valve (THV) therapies have shown to be an alternative to surgical valve replacement, especially in high-risk patients requiring redo surgery. However, reports of transcatheter-based interventions in tricuspid valve position are scarce. Case Description  Here, we report a case of successful concomitant transcatheter aortic valve-in-valve (ViV) and tricuspid valve-in-ring (ViR) procedures using a 23-mm CoreValve Evolut R THV (Medtronic, Inc., Minneapolis, Minnesota, United States) in aortic position and a 29-mm SAPIEN3 (Edwards Lifesciences, Inc., Irvine, California, United States) THV in tricuspid position. Conclusion  This case demonstrates feasibility of concomitant transcatheter aortic ViV and tricuspid ViR procedures.

Ejemplares similares